Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer
Hong Pan(Binzhou Medical University), Kathleen Kelly(National Cancer Institute), Eva Corey(University of Washington), Keith H. Jansson(National Cancer Institute), Lei Fang(Jiujiang University), Supreet Agarwal(University of Iowa), Ying Zhang(Fudan University), Jie Liu(Kunming Medical University), Huiting Fan(Guang’anmen Hospital), Hongsheng Lin(Kunming Institute of Botany), Holly M. Nguyen(University of Washington), JuanJuan Yin(National Cancer Institute), Michael L. Beshiri(National Cancer Institute)
Cited by 45
Related Papers
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
|Journal for ImmunoTherapy of Cancer|2018|314
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer
|Nature Communications|2014|269
A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening
|Clinical Cancer Research|2018|236
NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing
|Nature Communications|2023|203